We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

236 hedge funds and large institutions have $2.74B invested in Bio-Rad Laboratories Class A in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,566% more call options, than puts

Call options by funds: $2.85M | Put options by funds: $61K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

8% more capital invested

Capital invested by funds: $2.53B → $2.74B (+$203M)

1.81% more ownership

Funds ownership: 76.97% → 78.78% (+1.8%)

2% more funds holding

Funds holding: 232 → 236 (+4)

2% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 83

Holders
236
Holders Change
+4
Holders Change %
+1.72%
% of All Funds
6.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
25
Increased
85
Reduced
83
Closed
18
Calls
$2.85M
Puts
$61K
Net Calls
+$2.79M
Net Calls Change
-$2.53M

Top Buyers

Rank Fund Capital Flow
1
CM
Corvex Management
New York
+$69.5M
2
Morgan Stanley
Morgan Stanley
New York
+$21M
3
CS
Credit Suisse
Switzerland
+$20.7M
4
NIMC
NWQ Investment Management Company
California
+$11.5M
5
EAM
EverPoint Asset Management
Connecticut
+$9.98M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$14.8M
2
Renaissance Technologies
Renaissance Technologies
New York
-$13.9M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$10.3M
4
GAM
Gotham Asset Management
New York
-$9.26M
5
BG
BlackRock Group
United Kingdom
-$7.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$31.3M -$625K -4,379 -2%
GIM
27
Granahan Investment Management
Massachusetts
$27.7M -$2.82M -19,800 -9%
RA
28
Royce & Associates
New York
$25.5M -$2.04M -14,300 -7%
Norges Bank
29
Norges Bank
Norway
$24.1M – – –
Morgan Stanley
30
Morgan Stanley
New York
$22.7M +$21M +146,904 +1,270%
TM
31
Tikvah Management
North Carolina
$19.7M – – –
Geode Capital Management
32
Geode Capital Management
Massachusetts
$19.4M +$770K +5,401 +4%
EARNEST Partners
33
EARNEST Partners
Georgia
$19.1M -$308K -2,157 -2%
Franklin Resources
34
Franklin Resources
California
$18.8M -$941K -6,600 -5%
SGA
35
Sector Gamma AS
Norway
$18.5M -$519K -3,640 -3%
PAMP
36
Polar Asset Management Partners
Ontario, Canada
$18.4M +$488K +3,422 +3%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$16.3M -$216K -1,515 -1%
First Trust Advisors
38
First Trust Advisors
Illinois
$16.3M +$9.38M +65,785 +137%
NFA
39
Nationwide Fund Advisors
Ohio
$14.4M -$583K -4,087 -4%
MAM
40
Martingale Asset Management
Massachusetts
$14.2M +$413K +2,895 +3%
ICOM
41
Investment Counselors of Maryland
Maryland
$13.1M – – –
PPA
42
Parametric Portfolio Associates
Washington
$13M -$2.86M -20,028 -18%
TCIM
43
TIAA CREF Investment Management
New York
$12.8M -$16.1K -113 -0.1%
AQR Capital Management
44
AQR Capital Management
Connecticut
$12.8M -$5.94M -41,618 -32%
Charles Schwab
45
Charles Schwab
California
$12.6M +$365K +2,559 +3%
PCM
46
Portolan Capital Management
Massachusetts
$12.2M +$1.07M +7,489 +10%
Select Equity Group
47
Select Equity Group
New York
$12M -$301K -2,109 -2%
Principal Financial Group
48
Principal Financial Group
Iowa
$11.2M +$1.22M +8,552 +12%
SAM
49
Sentinel Asset Management
Vermont
$10.8M +$496K +3,476 +5%
Goldman Sachs
50
Goldman Sachs
New York
$10.7M -$5.15M -36,077 -33%
1
2
3 4 5

BIO Hedge Fund Activity: Q2 2016 in Review

236 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2016, worth a combined $2.74B — up 8% from $2.53B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIO positions and 18 closed out — a net gain of 7 holders — while 85 added to existing stakes and 83 trimmed.

The largest buyer was Corvex Management, opening a new position worth an estimated $69.5M. The largest seller was BlackRock Advisors, cutting an estimated $14.8M.

  • 236 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2016, up from 232 in Q1 2016.
  • Funds reported $2.74B of Bio-Rad Laboratories Class A stock for Q2 2016, up 8% quarter-over-quarter.
  • 25 funds opened new Bio-Rad Laboratories Class A positions in Q2 2016 and 18 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2016 was Corvex Management, an estimated $69.5M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2016 was BlackRock Advisors, an estimated $14.8M sold.

Based on aggregated 13F filings for Q2 2016.